Huntington's disease trials in New Zealand
4 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
- Where
- Christchurch
- Age
- 21 years to 70 years
- People
- 32 worldwide
- Run by
- Sarepta Therapeutics, Inc.
See details and how to joinNCT07536061 - Phase 2/3Enrolling by invitationAn Extension of SKY-0515 in Participants With Huntington's Disease
- Where
- Auckland, Christchurch, Wellington
- Age
- 25 years and over
- People
- 500 worldwide
- Run by
- Skyhawk Therapeutics, Inc.
See details and how to joinNCT07537075 - No phaseTaking peopleHDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
- Where
- Christchurch, Grafton
- Age
- 11 years to 75 years
- People
- 2,500 worldwide
- Run by
- University College, London
See details and how to joinNCT02855476 - No phaseTaking peopleEnroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
- Where
- Auckland, Christchurch, Wellington
- Age
- 18 years and over
- People
- 35,000 worldwide
- Run by
- CHDI Foundation, Inc.
See details and how to joinNCT01574053